Age-related increases in plasma phosphatidyicholine hydroperoxide concentrations in control subjects and patients with hyperlipidemia

Clinical Chemistry

Volumn 46, Issue 6, 2000, Pages 822-828

  Kinoshita, Mikio ^a,c   Oikawa, Shinichi ^b,d   Hayasaka, Kyoko ^b   Sekikawa, Akihiro ^b   Nagashima, Tazuko ^a   Toyota, Takayoshi ^b   Miyazawa, Teruo ^a  

^a TOHOKU UNIVERSITY   (Japan)

^b TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c OBIHIRO UNIVERSITY OF AGRICULTURE AND VETERINARY MEDICINE   (Japan)

^d NIPPON MEDICAL SCHOOL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

HYDROPEROXIDE; PHOSPHATIDYLCHOLINE;

ADOLESCENT; ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; CHEMOLUMINESCENCE; CHILD; ENDOTHELIUM CELL; FEMALE; FOAM CELL; HUMAN; HYPERLIPIDEMIA; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPID PEROXIDATION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; QUANTITATIVE ASSAY;

EID: 0034130871     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/46.6.822     Document Type: Article

References (36)

1. 1. Anderson KM, Castelli WP, Levy D. Cholesterol and mortality: 30 years of follow-up from the Framingham Study. JAMA 1987;257: 2176-80.
2. 2. Goldstein JL, Hazzard WR, Schrott HG, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. I. Lipid levels in 500 survivors of myocardial infarction. J Clin Investig 1973;52:1533-43.
3. 3. Goldstein JL, Schrott HG, Hazzard WR, Bierman EL, Motulsky AG. Hyperlipidemia in coronary heart disease. II. Genetic analysis of lipid levels in 176 families and delineation of a new inherited disorder, combined hyperlipidemia. J Clin Investig 1973;52: 1544-68.
4. 4. Kannel WB, Castelli WP, Gordon T, McNamara PM. Serum cholesterol, lipoproteins, and risk of coronary heart disease. Ann Intern Med 1974;74:1-12.
5. 5. Miller NE. Associations of high-density lipoprotein subclasses and apolipoproteins with ischemic heart disease and coronary atherosclerosis. Am Heart J 1987;113:589-97.
6. 6. Castelli WP, Garrison RJ, Wilson PWF, Abbott RD, Kalousdian S, Kannel WB. Incidence of coronary heart disease and lipoprotein cholesterol levels. The Framingham Study. JAMA 1986;256: 2835-8.
7. 7. Steinberg D, Parthasarathy S, Carew TE, Khoo JC, Witztum JL. Beyond cholesterol. Modification of low density lipoprotein that increase its atherogenicity. N Engl J Med 1989;320:915-24.
8. 8. Aqel NM, Ball H, Waldman H, Mitchinson MJ. Monocytic origin of foam cells in human atherosclerotic plaques. Atherosclerosis 1984;53:265-71.
9. 9. Steinbrecher UP, Parthasarathy S, Leake DS, Witztum JL, Steinberg D. Modification of low density lipoprotein by endothelial cells involves lipid peroxidation and degradation of low density lipoprotein phospholipids. Proc Natl Acad Sci U S A 1984;81:3883-7.
10. 10. Quinn MT, Parthasarathy S, Fong LG, Steinberg D. Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis. Proc Natl Acad Sci U S A 1987;84:2995-8.
11. 11. Parthasarathy S, Printz DJ, Boyd D, Joy L, Steinberg D. Macrophage oxidation of low density lipoprotein generates a modified form recognized by the scavenger receptor. Arteriosclerosis 1986; 6:505-10.
12. 12. Kodama T, Freeman M, Rohrer L, Zabrecky J, Matsudaira P, Krieger M. Type I macrophage scavenger receptor contains α-helical and collagen-like coiled coils. Nature 1990;343:531-5.
13. 13. Rohrer L, Freeman M, Kodama T, Penman M, Krieger M. Coiledcoil fibrous domains mediate ligand binding by macrophage scavenger receptor type II. Nature 1990;343:570-2.
14. 14. Morel DW, Hessler JR, Chisolm GM. Low density lipoprotein induced by free radical peroxidation of lipid. J Lipid Res 1983;24: 1070-6.
15. 15. Yagi K. Increased serum lipid peroxides initiate atherogenesis. Bioassays 1984;1:58-60.
16. 16. Glavind J, Hartmann S, Clemmensen J, Jessen E, Dam H. Studies on the role of lipoperoxides in human pathology. Acta Pathol Microbiol Scand 1952;30:1-6.
17. 17. Marshall PJ, Warso MA, Lands WE. Selective microdetermination of lipid hydroperoxides. Anal Biochem 1985;145:192-9.
18. 18. Schmuck A, Fuller CJ, Devaraj S, Jialal I. Effect of aging on susceptibility of low-density lipoproteins to oxidation. Clin Chem 1995;41:1628-32.
19. 19. Miyazawa T. Determination of phospholipid hydroperoxides in human blood plasma by a chemiluminescence-HPLC methods. Free Radic Biol Med 1989;7:209-17.
20. 20. Miyazawa T, Suzuki T, Fujimoto K, Yasuda K. Chemiluminescent simultaneous determination of phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide in the liver and brain of the rat. J Lipid Res 1992;33:1051-9.
21. 21. Miyazawa T, Fujimoto K, Suzuki T, Yasuda K. Determination of phospholipid hydroperoxides using luminol chemiluminescence-high-performance liquid chromatography. Methods Enzymol 1994; 233:324-32.
22. 22. Miyazawa T, Yasuda K, Fujimoto K, Kaneda T. Presence of phosphatidylcholine hydroperoxide in human plasma. J Biochem 1988;103:744-6.
23. 23. Suzuki T, Miyazawa T, Fujimoto K, Otsuka M, Tsutsumi M. Age-related accumulation of phosphatidylcholine hydroperoxide in cultured human diploid cells and its prevention by α-tocopherol. Lipids 1993;28:775-8.
24. 24. Miyazawa T, Suzuki T, Fujimoto K. Age-dependent accumulation of phosphatidylcholine hydroperoxide in the brain and liver of the rat. Lipids 1993;28:789-93.
25. 25. Bartlett GR. Phosphorus compounds in the human erythrocyte. Biochim Biophys Acta 1968;156:221-30.
26. 26. Kates M. Techniques of lipidology, 2nd ed. Amsterdam: Elsevier, 1986:100-11.
27. 27. Sanderson KJ, van-Rij AM, Wade CR, Sutherland WH. Lipid peroxidation of circulating low density lipoproteins with age, smoking and in peripheral vascular disease. Atherosclerosis 1995;118: 45-51.
28. 28. Miyazawa T, Suzuki T, Fujimoto K, Kinoshita M. Age-related change of phosphatidylcholine hydroperoxide and phosphatidylethanolamine hydroperoxide levels in normal human red blood cells. Mech Ageing Dev 1996;86:145-50.
29. 29. Heinecke JW, Rosen H, Chait A. Iron and copper promote modification of low density lipoprotein by human arterial smooth muscle cells in culture. J Clin Investig 1984;74:1890-4.
30. 30. Steinbrecher UP. Role of Superoxide in endothelial-cell modification of low-density lipoproteins. Biochim Biophys Acta 1988;959: 20-30.
31. 31. Hiramatsu K, Rosen H, Heinecke JW, Wolfbauer G, Chait A. Superoxide initiates oxidation of low density lipoprotein by human monocytes. Arteriosclerosis 1987;7:55-60.
32. 2+/ ascorbate/EDTA-induced lipid peroxidation. Biochim Biophys Acta 1993;1166:264-74.
33. 33. Rankin SM, Parthasarathy S, Steinberg D. Evidence for a dominant role of lipoxygenase(s) in the oxidation of LDL by mouse peritoneal macrophages. J Lipid Res 1991;32:449-56.
34. 34. Bowry VW, Stanley KK, Stocker R. High density Iipoprotein is the major carrier of lipid hydroperoxides in human blood plasma from fasting donors Proc Natl Acad Sci U S A 1992;89:10316-20.
35. 35. Bradley WA, Gianturco SH. Triglyceride-rich lipoproteins and atherosclerosis: pathophysiological consideration. J Intern Med Suppl 1994;236:33-9.
36. 36. Ursini F, Maiorino M, Gregolin C. The selenoenzyme phospholipid hydroperoxide glutathione peroxidase. Biochim Biophys Acta 1985;839:62-70.